Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1

Conditions

Urinary Bladder Neoplasms 1Respiratory Sounds 1Postoperative Complications 1Liver Cirrhosis 1Leukemia 1Hypoxia 1Hemorrhage 1Edema 1Dyspnea, Paroxysmal 1Dyspnea 1Brain Neoplasms 1

Interventions

Cyclophosphamide 21fludarabine phosphate 13Cyclosporine 11Antilymphocyte Serum 11Peripheral Blood Stem Cell Transplantation 10Methotrexate 10Busulfan 10Cytarabine 9Filgrastim 8Radiotherapy 7Dexamethasone 7Whole-Body Irradiation 6Mycophenolic Acid 6Methylprednisolone 6Melphalan 6Exercise 6fludarabine 5Vincristine 5Daunorubicin 5Cord Blood Stem Cell Transplantation 5pegaspargase 4Rituximab 4Palliative Care 4Mercaptopurine 4Etoposide 4Early Intervention, Educational 4Blood Specimen Collection 4Asparaginase 4Alemtuzumab 4Thioguanine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia × Furosemide × Clear all
NCT01508260 2013-04-05

Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

M.D. Anderson Cancer Center

Phase NA Withdrawn
OtherOther hematologic neoplasm

Hypoxia, Dyspnea, Dyspnea, Paroxysmal, Edema, Leukemia, Respiratory Sounds

Data powered by HemOnc (CC BY 4.0) Colophon âš¡